Although the evidence for beneficial effects of IgM-enriched Immunoglobulins inpatients with severe sepsis and septic shock has not always been supportive,systematic reviews have generally concluded that IgM-enriched immunoglobulinpreparations are associated with a reduction in mortality [25, 26, 27, 28, 29, 30]. The gene discussed is CD40LG; the disease is Sepsis.